Neoadjuvant Treatment With Cyclooxygenase-2 Inhibitor and Prednisolone Allows Conservative Surgery for Inflammatory Myofibroblastic Tumor of the Bladder

被引:12
|
作者
Tsuma, Yusuke [1 ]
Miyachi, Mitsuru [1 ]
Ouchi, Kazutaka [1 ]
Tsuchiya, Kunihiko [1 ]
Iehara, Tomoko [1 ]
Naitoh, Yasuyuki [2 ]
Konishi, Eiichi [3 ]
Yanagisawa, Akio [3 ]
Hosoi, Hajime [1 ]
机构
[1] Kyoto Prefectural Univ Med, Dept Pediat, Kyoto, Japan
[2] Kyoto Prefectural Univ Med, Dept Urol, Grad Sch Med Sci, Kyoto, Japan
[3] Kyoto Prefectural Univ Med, Dept Pathol, Kyoto, Japan
关键词
inflammatory myofibroblastic tumor; cyclooxygenase-2; neoadjuvant treatment; PLASMA-CELL GRANULOMA; THERAPY; LUNG;
D O I
10.1097/MPH.0000000000000604
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Inflammatory myofibroblastic tumor (IMT), which expresses cyclooxygenase-2 (COX-2), can be effectively treated with COX-2 inhibitor. Here, we report a case of urinary bladder IMT in a 13-year-old boy. Although total cystectomy was initially planned for complete resection of the tumor, neoadjuvant treatment with COX-2 inhibitor and prednisolone reduced the size of the tumor and enabled complete resection of the tumor by partial cystectomy. Neoadjuvant treatment with COX-2 inhibitor and prednisolone for IMT of the bladder allowed a more conservative surgical procedure that preserved bladder function.
引用
收藏
页码:E283 / E285
页数:3
相关论文
共 50 条
  • [11] Transurethral Resection for the Treatment of an Inflammatory Myofibroblastic Tumor of the Urinary Bladder: A Case Report
    Fadaak, Kamel
    Al-Otaibi, Aali
    Al-Zahrani, Abdullah
    Alhaam, Abdullah
    Al-Dandan, Omran
    Kussaibi, Haitham
    Al-Sowayan, Osama
    Aldamanhori, Reem
    CASE REPORTS IN ONCOLOGY, 2019, 12 (02): : 344 - 353
  • [12] Use of a cyclooxygenase-2 specific inhibitor for treatment of hyperprostaglandine syndrome
    Nüsing, RM
    Reinalter, S
    Klein, T
    Seyberth, HW
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R747 - R747
  • [13] Preoperative oral treatment with cyclooxygenase-2 inhibitor for cystitis glandularis
    Yanagi, Masato
    Motoda, Norio
    Katsu, Akifumi
    Kono, Hiroyoshi
    Kimata, Ryoji
    Hamasaki, Tsutomu
    Kondo, Yukihiro
    IJU CASE REPORTS, 2024, 7 (04) : 297 - 300
  • [14] Minimally invasive surgery for inflammatory myofibroblastic tumor of the urinary bladder Three case reports
    Xu, He
    He, Ben
    Tu, Xiang
    Bao, Yige
    Yang, Lu
    Zhuo, Hui
    Wei, Qiang
    MEDICINE, 2018, 97 (49)
  • [15] Successful preoperative treatment of pediatric bladder inflammatory myofibroblastic tumor with anti-inflammatory therapy
    Berger, Alisa
    Kim, Christina
    Hagstrom, Nathan
    Ferrer, Fernando
    UROLOGY, 2007, 70 (02) : 372.e13 - 372.e15
  • [16] A Case of ALK-Rearranged Inflammatory Myofibroblastic Tumor of the Bladder with Remarkable Response to ALK Inhibitor
    Sakai, Yuta
    Ikawa, Yasuhiro
    Takenaka, Mika
    Noguchi, Kazuhiro
    Fujiki, Toshihiro
    Kuroda, Rie
    Nomura, Kozo
    Sakai, Seisho
    Wada, Taizo
    PEDIATRIC BLOOD & CANCER, 2021, 68
  • [17] Anaplastic Lymphoma Kinase Inhibitor in Treatment of Inflammatory Myofibroblastic Tumor of the Tongue in Infancy
    Rao, Karishma
    Farooki, Sana
    Guest, Erin
    Chastain, Katherine
    Gener, Melissa
    Akangire, Gangaram
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (04) : E521 - E524
  • [18] Rationale for use of cyclooxygenase-2 inhibitors in prevention and treatment of bladder cancer
    Pruthi, RS
    Derksen, E
    Gaston, K
    Wallen, EM
    UROLOGY, 2004, 64 (04) : 637 - 642
  • [19] Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis
    Goldenberg, MM
    CLINICAL THERAPEUTICS, 1999, 21 (09) : 1497 - 1513
  • [20] Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor
    Petersen, C
    Petersen, S
    Milas, L
    Lang, FF
    Tofilon, PJ
    CLINICAL CANCER RESEARCH, 2000, 6 (06) : 2513 - 2520